|
1
|
Bishop MW, Janeway KA and Gorlick R:
Future directions in the treatment of osteosarcoma. Curr Opin
Pediatr. 28:26–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang Z, Li X, Yang Y, He Z, Qu X and Zhang
Y: Long noncoding RNAs in the progression, metastasis, and
prognosis of osteosarcoma. Cell Death Dis. 7:e23892016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee C and Kikyo N: Strategies to identify
long noncoding RNAs involved in gene regulation. Cell Biosci.
2:372012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mattick JS: Non-coding RNAs: The
architects of eukaryotic complexity. EMBO Rep. 2:986–991. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Di Gesualdo F, Capaccioli S and Lulli M: A
pathophysiological view of the long non-coding RNA world.
Oncotarget. 5:10976–10996. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang L, Li C, Lan T, Wu L, Yuan Y, Liu Q
and Liu Z: Decreased expression of long non-coding RNA GAS5
indicates a poor prognosisand promotes cell proliferation and
invasion in hepatocellular carcinoma by regulating vimentin. Mol
Med Rep. 13:1541–1550. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lalevee S and Feil R: Long noncoding RNAs
in human disease: Emerging mechanisms and therapeutic strategies.
Epigenomics. 7:877–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smolle MA and Pichler M: The role of long
non-coding RNAs in osteosarcoma. Noncoding RNA. 4(pii):
E72018.PubMed/NCBI
|
|
10
|
Su F, He W, Chen C, Liu M, Liu H, Xue F,
Bi J, Xu D, Zhao Y, Huang J, et al: The long non-coding RNA
FOXD2-AS1 promotes bladder cancer progression and recurrence
through a positive feedback loop with Akt and E2F1. Cell Death Dis.
9:2332018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiong Y, Wang T, Wang M, Zhao J, Li X,
Zhang Z, Zhou Y, Liu J, Jia L and Han Y: Long non-coding RNAs
function as novel predictors and targets of non-small cell lung
cancer: A systematic review and meta-analysis. Oncotarget.
9:11377–11386. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Fan D, Jian Z, Chen GG and Lai
PB: Cancer specific long noncoding RNAs show differential
expression patterns and competing endogenous RNA potential in
hepatocellular carcinoma. PLoS One. 10:e1410422015.
|
|
13
|
Chen X, Yang TT, Wang W, Sun HH, Ma BA, Li
CX, Ma Q, Yu Z and Fan QY: Establishment and characterization of
human osteosarcoma cell lines with different pulmonary metastatic
potentials. Cytotechnology. 61:37–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Benjamin RS: Osteosarcoma: Better
treatment through better trial design. Lancet Oncol. 16:12–13.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Durnali A, Alkis N, Cangur S, Yukruk FA,
Inal A, Tokluoglu S, Seker MM, Bal O, Akman T, Inanc M, et al:
Prognostic factorsfor teenage and adult patients with high-grade
osteosarcoma: An analysis of 240 patients. Med Oncol. 30:6242013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miller BJ, Cram P, Lynch CF and Buckwalter
JA: Risk factors for metastatic disease at presentation with
osteosarcoma: An analysis of the SEER database. J Bone Joint Surg
Am. 95:e892013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chan JJ and Tay Y: Noncoding RNA: RNA
regulatory networks in cancer. Int J Mol Sci. 19(pii): E13102018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang YL, Shao J, Wu X, Li T, Xu M and Shi
D: A long non-coding RNA signature for predicting survival in
patients with colorectal cancer. Oncotarget. 9:21687–21695.
2017.PubMed/NCBI
|
|
20
|
Tuo YL, Li XM and Luo J: Long noncoding
RNA UCA1 modulates breast cancer cell growth and apoptosis through
decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol Sci.
19:3403–3411. 2015.PubMed/NCBI
|
|
21
|
Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao
X, Chen WS and Li B: LncRNA-UCA1 exerts oncogenic functions in
non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett.
371:99–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arab K, Park YJ, Lindroth AM, Schäfer A,
Oakes C, Weichenhan D, Lukanova A, Lundin E, Risch A, Meister M, et
al: Long noncoding RNA TARID directs demethylation and activation
of the tumor suppressor TCF21 via GADD45A. Mol Cell. 55:604–614.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen F, Mo J and Zhang L: Long noncoding
RNA BCAR4 promotes osteosarcoma progression through activating
GLI2-dependent gene transcription. Tumour Biol. 37:13403–13412.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun XH, Yang LB, Geng XL, Wang R and Zhang
ZC: Increased expression of lncRNA HULC indicates a poor prognosis
and promotes cell metastasis in osteosarcoma. Int J Clin Exp
Pathol. 8:2994–3000. 2015.PubMed/NCBI
|
|
25
|
Cao L, Wang Y, Wang Q and Huang J: LncRNA
FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by
acting as a sponge of miR-206 to modulate CCND1 expression. Biomed
Pharmacother. 106:1220–1226. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang X, Duan B and Zhou X: Long non-coding
RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by
regulating EMT and Notch signaling pathway. Eur Rev Med Pharmacol
Sci. 21:3586–3591. 2017.PubMed/NCBI
|
|
27
|
Hainaut P and Plymoth A: Targeting the
hallmarks of cancer: Towards a rational approach to next-generation
cancer therapy. Curr Opin Oncol. 25:50–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ou Y, Wang SJ, Jiang L, Zheng B and Gu W:
p53 Protein-mediated regulation of phosphoglycerate dehydrogenase
(PHGDH) is crucial for the apoptotic response upon serine
starvation. J Biol Chem. 290:457–466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jing Z, Heng W, Xia L, Ning W, Yafei Q,
Yao Z and Shulan Z: Downregulation of phosphoglycerate
dehydrogenase inhibits proliferation and enhances cisplatin
sensitivity in cervical adenocarcinoma cells by regulating Bcl-2
and caspase-3. Cancer Biol Ther. 16:541–548. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fellenberg J, Bernd L, Delling G, Witte D
and Zahlten- Hinguranage A: Prognostic significance of
drug-regulated genes in high-grade osteosarcoma. Mod Pathol.
20:1085–1094. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independentregulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language. Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
